Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-month, Open-label, Safety Trial Of Pregabalin In Adolescent Patients With Fibromyalgia

NCT01020526 is registered in ClinicalTrials.gov with Pfizer's Upjohn has merged with Mylan to form Viatris Inc. as lead sponsor.

NCT NCT01020526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01020526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-month, Open-label, Safety Trial Of Pregabalin In Adolescent Patients With Fibromyalgia
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2010
Completion date
June 30, 2015
Enrollment
63 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia